Spots Global Cancer Trial Database for Optical Coherence Microscopy in Dermato-oncology

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Optical Coherence Microscopy in Dermato-oncology

Official Title: In Vivo Imaging Innovation : Optical Coherence Microscopy in Dermato-oncology

Study ID: NCT03079232

Conditions

Skin Cancer

Interventions

OCTAV Patient

OCTAV Control group

Study Description

Brief Summary: OCTAV is a medical device class I, not CE marked, based on a new technique for high-resolution imager (cell) internal microstructures of all types of biological tissues in vivo or ex vivo, to a depth of penetration 800 .mu.m. It allows to explore the epidermis, the dermo-epidermal junction and middle dermis in a totally non-invasive (direct contact with the tissue without sampling).

Detailed Description: At the coming of the patient in Dermatology for resection / biopsy of the tumor (usual practice), for the study, an image of the tumor will be performed with the OCTAV device (about 5 minutes) for the study. Then, according to usual practice, resection / biopsy will be performed. This study aims to validate the clinical relevance of this device to characterize the 3 main skin cancers and to obtain the necessary data for the implementation of future clinical trials.